Antimicrobials | PediCap

Transição precoce para Amoxicilina oral: seguro e eficaz em crianças hospitalizadas com Pneumonia Grave

2025

Presented by: Sidat M. M

Presented at: Jornadas Nacionais de Saude

Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP

2025

Presented by: Sidat M. M, em nome da equipe do ensaio PediCAP

Presented at: Simpósio Pré-Evento, XIII Conferência Científica da UEM

Tolerability and Acceptability of Dispersible Oral Tablets of Amoxicillin and Co-Amoxiclav in African Children Hospitalized with Severe Pneumonia: Results from the PediCAP trial

2025

Presented by: Sidat MM, on behalf of the PediCAP trial team

Presented at: INSPiRED

Early oral step-down to amoxicillin is safe and effective for children hospitalised with severe community-acquired pneumonia: the PediCAP trial

2024

Presented by: Musiime V on behalf of the PediCAP trial team

Presented at: 20th UPA Annual Scientific Conference 2024

View presentation slides

Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP

2024

Authors: Issa F, Sidat M, Joaquim W, Maieca A, Massitela C, Adriano Q, Cassia U, Martins S, Chilundo J, Manjate N, Macanze E, Sigaúque A, Chilengue R, Bombe M, Florindo N, Nhacumba S, Buck WC, Sacarlal J, Musiime V, Sharland M, grupo do ensaio PediCAP

Presented at: Jornadas de AMOPE 2024

View presentation slides

New amoxicillin-clavulanate dispersible tablets in children: a population pharmacokinetic analysis

2024

Authors: Dyk vJ on behalf of the PediCAP team

Presented at: PAGE 2024

Read more

Early oral step-down to amoxicillin is safe and effective for children hospitalised with severe community-acquired pneumonia: the PediCAP trial

2024

Authors: Musiime V on behalf of the PediCAP trial team

Presented at: ESCMID Global 2024

Read More

Navigating the COVID-19 Pandemic for Participant Recruitment and Follow-up: Experiences from the PediCAP Clinical Trial Consortium

2023

Authors: Kiggwe A, Nalwanga D, Tagoola A, Madhi S, Moore PD, Archary M, Mulenga V, Mujuru AH, Sacarlal J, Buck WC, Sidat M, Nguyen H, Haque F, Dennis E, Clements M, Murphy B, Spittle B, Viero F, Bielicki J, Musiime V,  Sharland M

Presented at: The EDCTP Forum 2023

Read more

External factors affecting recruitment in a global paediatric pneumonia trial: lessons learned from PediCAP

2023

Authors: Pillay K, Archary M, Bielicki J, Buck WC, Clements M, Dennis E, Goelen J, Haque F, Kiggwe A, Madhi S, Moore PD, Mujuru AH, Mulenga V, Murphy B, Musiime V, Nalwanga D, Nguyen H, Sacarlal J, Sidat M, Spittle B, Tagoola A, Viero F, Sharland M

Presented at: The EDCTP Forum 2023

Read more

Building a national network for inpatient pediatric clinical research in Mozambique 

2023

Authors: Sacarlal WJ, Buck C, Passanduca A, Macassa E, Saíde A, Chhaganlal K, Gafur M, Seni A, Machava S, Martins L, Issa F, Macanze E, Manjate N, Chaúque S, Langa S, Sidat M, Cassia U, Salimo A, Mavume C, Massitela C, Maieca A, Joaquim W, Martins S, Adriano Q, Zandamela M, Bramugy J, Bassat Q, Moraleda C, Tagarro A, Sharland M, Rojo P

Presented at: The EDCTP Forum 2023

Read more

Receipt of intravenous co-amoxiclav challenged eligibility screening for the PediCAP Trial in Johannesburg, South Africa 

2023

Authors: Moore PD, Waggie Z, Nkosi S, Nkosi L, Kumalo N, Nkumana N, Zulu N, Dangor Z, Sharland M, Madhi S

Presented at: The EDCTP Forum 2023

Read more

Global estimates of the relative pediatric consumption and cost of oral amoxicillin and amoxicillin plus clavulanic acid

2021

Authors: G. A. Levine, M. Sharland, S. Ellis, Y. Ferrisse, C. Loze, Y. Hsia, G. Fink, J. Bielicki; for the PediCAP project

Presented at: ECCMID 2021

View e-poster

1